Announcements

The Journal of Cardiovascular Development and Disease (JCDD, ISSN: 2308-3425) is an international, scientific, peer-reviewed, and open access journal on cardiovascular medicine, published monthly online by MDPI.

JCDD aims to provide a professional publishing service to the scientific community and has strived towards the effective dissemination of high-quality scientific work. In order to support the scientific community and contribute to the faster distribution of important scientific research, JCDD has been working to facilitate academic conference collaborations.

The journal is now seeking collaborations with additional academic conferences and is open to a diverse range of collaborations, such as media partnerships, awards, exhibitions, and publications, amongst others.

The scope of JCDD includes, but is not limited to, the following:

• Gene regulation;
• Morphology;
• Cardiovascular anatomy;
• Cardiac physiology;
• Vascular biology;
• Gene patterns;
• Imaging techniques;
• Cardiac regeneration;
• Case studies;
• Congenital heart disease;
• Conduction system and arrhythmias;
• Animal models for cardiovascular diseases;
• Biophysics;
• Genetics;
• Cardiac surgery;
• Cardiovascular clinical research.

We welcome consultations with any conferences related to cardiovascular development and disease. If you are interested in collaborating with JCDD, please contact us at jcdd@mdpi.com.

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

• Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
• Writing a brief promotion plan for the Special Issue;
• Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
• Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

• Conducting a final check before the Special Issue is published online;
• Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
• Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
• Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
• Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

1. “Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?”
by Giandomenico Bisaccia, Fabrizio Ricci, Vittoria Recce, Antonio Serio, Giovanni Iannetti, Anwar A. Chahal, Marcus Ståhlberg, Mohammed Yunus Khanji, Artur Fedorowski and Sabina Gallina
J. Cardiovasc. Dev. Dis. 2021, 8(11), 156; https://doi.org/10.3390/jcdd8110156
Full text available online: https://www.mdpi.com/2308-3425/8/11/156

2. “Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review”
by Fotios Barkas, Chrysoula-Paraskevi Styla, Aris Bechliouli, Haralampos Milionis and Evangelos Liberopoulos
J. Cardiovasc. Dev. Dis. 2021, 8(2), 18; https://doi.org/10.3390/jcdd8020018
Full text available online: https://www.mdpi.com/2308-3425/8/2/18

3. “Physiological Age- and Sex-Related Profiles for Local (Aortic) and Regional (Carotid-Femoral, Carotid-Radial) Pulse Wave Velocity and Center-to-Periphery Stiffness Gradient, with and without Blood Pressure Adjustments: Reference Intervals and Agreement between Methods in Healthy Subjects (3–84 Years)”
by Daniel Bia and Yanina Zócalo
J. Cardiovasc. Dev. Dis. 2021, 8(1), 3; https://doi.org/10.3390/jcdd8010003
Full text available online: https://www.mdpi.com/2308-3425/8/1/3

4. “Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis”
by Rashid Mir, Imadeldin Elfaki, Naina Khullar, Ajaz Ahmad Waza, Chandan Jha, Mohammad Muzaffar Mir, Shamsu Nisa, Babar Mohammad, Tahir Ahmad Mir, Mohsin Maqbool et al.
J. Cardiovasc. Dev. Dis. 2021, 8(2), 22; https://doi.org/10.3390/jcdd8020022
Full text available online: https://www.mdpi.com/2308-3425/8/2/22

5. “Potential Role of eNOS Genetic Variants in Ischemic Heart Disease Susceptibility and Clinical Presentation”
by Paolo Severino, Andrea D’Amato, Silvia Prosperi, Michele Magnocavallo, Marco Valerio Mariani, Lucrezia Netti, Lucia Ilaria Birtolo, Paolo De Orchi, Cristina Chimenti, Viviana Maestrin et al.
J. Cardiovasc. Dev. Dis. 2021, 8(9), 116; https://doi.org/10.3390/jcdd8090116
Full text available online: https://www.mdpi.com/2308-3425/8/9/116

6. “Extracellular Matrix-Based Biomaterials for Cardiovascular Tissue Engineering”
by Astha Khanna, Maedeh Zamani and Ngan F. Huang
J. Cardiovasc. Dev. Dis. 2021, 8(11), 137; https://doi.org/10.3390/jcdd8110137
Full text available online: https://www.mdpi.com/2308-3425/8/11/137

7. “From Stripes to a Beating Heart: Early Cardiac Development in Zebrafish”
by Cassie L. Kemmler, Fréderike W. Riemslagh, Hannah R. Moran and Christian Mosimann
J. Cardiovasc. Dev. Dis. 2021, 8(2), 17; https://doi.org/10.3390/jcdd8020017
Full text available online: https://www.mdpi.com/2308-3425/8/2/17

8. “Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine”
by Spencer R. Marsh, Zachary J. Williams, Kevin J. Pridham and Robert G. Gourdie
J. Cardiovasc. Dev. Dis. 2021, 8(5), 52; https://doi.org/10.3390/jcdd8050052
Full text available online: https://www.mdpi.com/2308-3425/8/5/52

9. “Physical Activity, Sedentary Behavior and Sleep Time: Association with Cardiovascular Hemodynamic Parameters, Blood Pressure and Structural and Functional Arterial Properties in Childhood”
by Mariana Gómez-García, Daniel Bia and Yanina Zócalo
J. Cardiovasc. Dev. Dis. 2021, 8(6), 62; https://doi.org/10.3390/jcdd8060062
Full text available online: https://www.mdpi.com/2308-3425/8/6/62

10. “Disagreement between Cardiac Troponin Tests Yielding a Higher Incidence of Myocardial Injury in the Emergency Setting”
by Peter A. Kavsak, Shawn E. Mondoux, Janet Martin, Mark K. Hewitt, Lorna Clark, Nadia Caruso, Ching-Tong Mark, V. Tony Chetty, Craig Ainsworth and Andrew Worster
J. Cardiovasc. Dev. Dis. 2021, 8(3), 31; https://doi.org/10.3390/jcdd8030031
Full text available online: https://www.mdpi.com/2308-3425/8/3/31

The Journal of Cardiovascular Development and Disease (JCDD, ISSN: 2308-3425) is an international, scientific, peer-reviewed, open access journal on cardiovascular medicine published monthly online by MDPI.

To develop different research areas and continue to attract high-quality papers, the Journal of Cardiovascular Development and Disease (JCDD) is recruiting Section Editors-in-Chief (https://www.mdpi.com/journal/jcdd/sections) for the following Sections:

• “Basic and Translational Cardiovascular Research”;
• “Cardiac Development and Regeneration”;
• “Pediatric Cardiology and Congenital Heart Disease”;
• “Acquired Cardiovascular Disease”;
• “Electrophysiology and Cardiovascular Physiology”;
• “Genetics”;
• “Epidemiology, Lifestyle, and Cardiovascular Health”;
• “Imaging”;
• “Stroke and Cerebrovascular Disease”;
• “Cardiovascular Clinical Research”;
• “Cardiac Surgery”.

The Section Editor-in-Chief is responsible for ensuring the scientific quality of a particular Section of a journal and is expected to oversee the growth and development of the journal Sections and its Board Members.

Responsibilities of the Section Editor-in-Chief include the following:

• Setting the scope and direction of the Section;
• Advising on the strategic development of the Section;
• Maintaining oversight of the editorial process for individual manuscripts in their Section (mainly by making the final decision regarding whether a paper can be published after peer review and revisions);
• Inviting distinguished scientists to join the Editorial Board;
• Suggesting topics for Special Issues;
• Coordinating the Section Editorial Board and stimulating their contributions to the journal;
• Promoting JCDD and increasing its visibility at academic conferences;
• Understanding, leading, and upholding MDPI’s peer review guidelines and ethics guidelines.

Please find more details at the following link: https://www.mdpi.com/editors#Editorial_Board_Responsibilities.

As a Section Editor-in-Chief, you will have the unique opportunity to network and communicate with scholars in the cardiovascular community, building long-term relationships and establishing your influence within your discipline. Appointed members will also receive an Editor Certificate confirming this role. In addition, you will have the opportunity to publish two papers per year free of charge in any of our journals. The term for this position is two years and can be renewed.

If you are a researcher in a related field and are passionate about participating in the publication of cutting-edge research, please do not hesitate to get in touch about joining the JCDD Editorial Board. To apply for this position, please contact the JCDD Editorial Office (jcdd@mdpi.com) with the following two files attached:

• A full academic CV;
• A short cover letter that details your interests and enthusiasm for the position.

JCDD Editorial Office

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

• Peer Review Week 2022
• Research Integrity
• What We’ve Learned About Peer Review Reports
• 4 Steps to the Perfect Peer Review Report
• How to Write the Perfect Peer Review Report: An Interview
• Inviting Great Peer Reviewers

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2022)

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

• Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
• Mateusz Maciejczyk, Medical University of Bialystok, Poland

Current Oncology:

• Matteo Lambertini, University of Genova, Italy

Dentistry Journal:

• Helen Rogers, Newcastle University, UK

Healthcare:

• Amir Karami, University of South Carolina, USA

Journal of Clinical Medicine:

• Andrea Palermo, Campus Bio-Medico University, Italy

Journal of Personalized Medicine:

• Simone Di Franco, University of Palermo, Italy
• Catriona Hippman, University of Calgary, Canada

Medicina:

• Veeru Kasivisvanathan, University College London, UK
• Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy

Pharmaceutics:

• Qi Zhou, Purdue University, USA